Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Biotech Industry Analysis

UpdatedAug 16, 2025
DataAggregated Company Financials
Companies54
  • 7D-0.2%
  • 3M-3.7%
  • 1Y-12.0%
  • YTD-16.1%

The Biotech is pretty flat in the last 7 days, but BioArctic has stood out, gaining 8.8%. As for the longer term, the industry has declined 11% in the last year. Earnings are forecast to grow by 24% annually.

Industry Valuation and Performance

Has the Swedish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 16 Aug 2025SEK 186.6bSEK 35.9bSEK 2.8b28.4x66.9x5.2x
Mon, 14 Jul 2025SEK 187.2bSEK 35.2bSEK 2.3b29.8x79.8x5.3x
Wed, 11 Jun 2025SEK 190.5bSEK 35.2bSEK 2.2b29.8x86.1x5.4x
Fri, 09 May 2025SEK 189.3bSEK 33.9bSEK 776.7m33x243.7x5.6x
Sun, 06 Apr 2025SEK 178.7bSEK 33.7bSEK 720.3m29.2x248.1x5.3x
Tue, 04 Mar 2025SEK 215.1bSEK 33.7bSEK 590.8m35.7x364.1x6.4x
Thu, 30 Jan 2025SEK 227.2bSEK 33.1b-SEK 4,401,172,950.26141.1x-51.6x6.9x
Sat, 28 Dec 2024SEK 220.0bSEK 33.0b-SEK 4,422,807,726.67160.2x-49.7x6.7x
Mon, 25 Nov 2024SEK 206.0bSEK 33.1b-SEK 4,544,855,818.46146.7x-45.3x6.2x
Wed, 23 Oct 2024SEK 213.5bSEK 31.4b-SEK 5,594,409,299.8451.1x-38.2x6.8x
Fri, 20 Sep 2024SEK 216.3bSEK 31.5b-SEK 5,544,383,051.8852x-39x6.9x
Sun, 18 Aug 2024SEK 207.7bSEK 31.4b-SEK 5,406,660,684.6649.6x-38.4x6.6x
Tue, 16 Jul 2024SEK 196.8bSEK 30.6b-SEK 5,499,843,693.7638.8x-35.8x6.4x
Thu, 13 Jun 2024SEK 190.2bSEK 30.6b-SEK 5,425,687,575.9838.5x-35.1x6.2x
Sat, 11 May 2024SEK 189.2bSEK 31.0b-SEK 5,223,723,859.8945.7x-36.2x6.1x
Mon, 08 Apr 2024SEK 181.4bSEK 29.8b-SEK 5,279,211,965.1161.5x-34.4x6.1x
Wed, 06 Mar 2024SEK 179.5bSEK 29.8b-SEK 5,619,009,226.2951.4x-31.9x6x
Fri, 02 Feb 2024SEK 287.2bSEK 28.7b-SEK 1,193,340,901.0058.9x-240.7x10x
Sun, 31 Dec 2023SEK 183.5bSEK 28.7b-SEK 1,197,137,927.0061.4x-153.3x6.4x
Tue, 28 Nov 2023SEK 171.4bSEK 28.7b-SEK 1,176,150,855.0053.4x-145.8x6x
Thu, 26 Oct 2023SEK 152.1bSEK 27.4b-SEK 2,000,171,347.0048.3x-76.1x5.5x
Sat, 23 Sep 2023SEK 164.8bSEK 27.4b-SEK 2,020,750,025.0050.2x-81.6x6x
Mon, 21 Aug 2023SEK 152.1bSEK 27.6b-SEK 1,607,974,738.0053.5x-94.6x5.5x
Wed, 19 Jul 2023SEK 157.8bSEK 26.5b-SEK 1,384,347,898.0046.7x-114x5.9x
Fri, 16 Jun 2023SEK 173.6bSEK 26.4b-SEK 1,256,573,575.0045x-138.2x6.6x
Sun, 14 May 2023SEK 174.6bSEK 26.3b-SEK 1,373,409,150.0046.6x-127.1x6.6x
Tue, 11 Apr 2023SEK 171.3bSEK 25.4b-SEK 2,037,827,771.0038.4x-84.1x6.7x
Thu, 09 Mar 2023SEK 169.9bSEK 25.4b-SEK 2,232,161,065.0038.7x-76.1x6.7x
Sat, 04 Feb 2023SEK 176.8bSEK 24.1b-SEK 1,832,166,009.0042.8x-96.5x7.3x
Mon, 02 Jan 2023SEK 155.4bSEK 23.8b-SEK 1,842,867,788.0031.5x-84.3x6.5x
Wed, 30 Nov 2022SEK 155.6bSEK 23.8b-SEK 1,731,577,419.0031.4x-89.9x6.5x
Fri, 28 Oct 2022SEK 149.7bSEK 23.9b-SEK 3,176,258,657.0033.5x-47.1x6.3x
Sun, 25 Sep 2022SEK 138.4bSEK 22.9b-SEK 3,319,741,669.0032.9x-41.7x6x
Tue, 23 Aug 2022SEK 167.1bSEK 22.6b-SEK 3,541,328,284.0036.1x-47.2x7.4x
Price to Earnings Ratio

-47.2x


Total Market Cap: SEK 167.1bTotal Earnings: -SEK 3,541,328,284.00Total Revenue: SEK 22.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Biotech Industry Price to Earnings3Y Average -38.3x202320242025
Current Industry PE
  • Investors are optimistic on the Swedish Biotechs industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 66.8x which is higher than its 3-year average PE of -38.4x.
  • The 3-year average PS ratio of 6.3x is higher than the industry's current PS ratio of 5.2x.
Past Earnings Growth
  • Total earnings for the Biotechs industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 17% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market0.35%
Healthcare0.073%
Biotech-0.18%
Biotech-0.18%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
BIOA B BioArcticSEK 238.209.6%
+SEK 1.8b		55.7%PE23.4x
SOBI Swedish Orphan BiovitrumSEK 273.800.4%
+SEK 344.6m		-11.8%PE21.6x
VITR VitrolifeSEK 136.300.6%
+SEK 108.3m		-38.8%PE40.6x
HAMLET B Hamlet BioPharmaSEK 4.2014.3%
+SEK 93.3m		1.4%PS4191x
CRNO B Cereno ScientificSEK 9.453.5%
+SEK 90.3m		61.0%PS35.2x

Latest News

XSPRAY
SEK 41.70
Xspray Pharma
7D
-15.7%
1Y
-17.3%
BIOA B
SEK 238.20
BioArctic
7D
9.6%
1Y
55.7%

Revenues Not Telling The Story For BioArctic AB (publ) (STO:BIOA B) After Shares Rise 26%

Aug 14
Revenues Not Telling The Story For BioArctic AB (publ) (STO:BIOA B) After Shares Rise 26%
MODTX
SEK 1.90
Modus Therapeutics Holding
7D
-50.4%
1Y
17.3%
ONCO
SEK 4.65
Oncopeptides
7D
-5.3%
1Y
114.3%
BIOVIC B
SEK 0.68
Biovica International
7D
5.6%
1Y
-76.0%
HNSA
SEK 28.94
Hansa Biopharma
7D
-4.7%
1Y
-25.3%
SOBI
SEK 273.80
Swedish Orphan Biovitrum
7D
0.4%
1Y
-11.8%

We Think Swedish Orphan Biovitrum (STO:SOBI) Can Stay On Top Of Its Debt

Aug 04
We Think Swedish Orphan Biovitrum (STO:SOBI) Can Stay On Top Of Its Debt
BONEX
SEK 282.20
Bonesupport Holding
7D
-9.2%
1Y
-0.8%
HAMLET B
SEK 4.20
Hamlet BioPharma
7D
14.3%
1Y
1.4%
VITR
SEK 136.30
Vitrolife
7D
0.6%
1Y
-38.8%
author-image

US IVF Treatment Rebound And APAC Reimbursements Will Drive Recovery

Recovery in IVF procedure volume and expansion in key regions will drive organic revenue growth and margin improvement as market conditions stabilize.
FLUO
SEK 40.30
FluoGuide
7D
3.6%
1Y
-1.0%

Health Check: How Prudently Does FluoGuide (STO:FLUO) Use Debt?

Jul 26
Health Check: How Prudently Does FluoGuide (STO:FLUO) Use Debt?
EGTX
SEK 5.46
Egetis Therapeutics
7D
-5.5%
1Y
3.2%
CRNO B
SEK 9.45
Cereno Scientific
7D
3.5%
1Y
61.0%
DMYD B
SEK 11.08
Diamyd Medical
7D
-3.5%
1Y
-40.4%
CURAS
DKK 3.57
Curasight
7D
4.4%
1Y
-69.5%
BINV
SEK 38.85
BioInvent International
7D
-2.1%
1Y
-6.6%